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Summary 
We  have  shown  previously that  dendritic  cells  (DC)  produce  IL-12 upon  interaction  with 
CD4+  T  cells. Here we ask how this IL-12 production is induced and regulated. Quantitative 
PCR. and in situ hybridization for IL-12 p40 and an ELISA specific for the p70 heterodimer 
were used to determine  IL-12 production.  We demonstrate  that ligation of either CD40  or 
MHC class  II  molecules independently trigger IL-12 production in DC,  and that IL-12 pro- 
duction is downregulated by IL-4 and IL-10. The levels ofbioactive IL-12 that can be released 
by triggering with an anti-CD40 mAb or with a T  cell hybridoma are high (range 260-4700 
pg/ml from 1 ￿  106 DC in 72 h). The CD40-mediated pathway indicates that IL-12 produc- 
tion is induced in DC upon interaction with activated, CD40 ligand-expressing helper T  cells, 
even in the absence of cognate antigen recognition. Side-by-side comparison oflL-12 produc- 
tion, and blocking experiments employing an anti-CD40 ligand n'LAb, suggest that the CD40- 
mediated pathway is quantitatively more significant than induction via the MHC class II mole- 
cule. The importance of the CD40/CD40 ligand interaction for IL-12 induction in DC likely 
contributes to the recent finding that mice lacking the CD40 ligand are impaired in mounting 
Thl  type cell-mediated immune responses. 
I 
L-12, a 70-kD heterodimeric cytokine composed of co- 
.valentty linked p35 and p40 chains has emerged as a cen- 
tral cytokine in the immune response (1).  IL-12 stimulates 
NK cells, mediates Thl development, and fosters CTL de- 
velopment.  It  can  be produced  by monocytes and  mac- 
rophages  in  response  to  intracellular  pathogens,  bacteria 
(e.g., staphylococci) and bacterial products. Recent reports 
indicate that dendritic cells (DC) also release bioactive IL-12. 
One report described that anti-IL-12 blocks the capacity of 
murine DC to skew the response of naive transgenic T  cells 
to the Thl phenotype (2),  and another shows induction of 
IL-12 p40/p35  mRNA  in  bone-marrow  derived  murine 
DC upon uptake ofmicroparticle-absorbed protein antigen 
(3).  Human epidermal Langerhans cells are also a source of 
IL-12 (4).  We have recently used several criteria for dem- 
onstration of IL-12 p40  and p35  mRNA as well as IL-12 
p40  and bioactive p70  proteins,  to  show that murine  and 
human DC release IL-12 upon conventional stimuli such as 
staphylococcus  aureus  (5).  We  also  found  that  DC  pro- 
duced bioactive IL-12 upon interaction with T  cells with- 
out  standard  stir  "  ~-,~h as bacterial products.  Here, we 
describe the regulation oflL-12 in DC. We show that liga- 
tion of CD40  and MHC class II molecules independently 
trigger IL-12 production by DC in large amounts, and that 
IL-12 release by DC is downregulated by IL-4 as well as by 
IL-10. 
Materials  and  Methods 
Mice.  Specific  pathogen-free C57BL/6, BALB/c, and C3H/ 
He mice of both sexes were purchased from Charles River (Sulz- 
feld, Germany) and used at 6 to 8 wk of age. 
Media and Reagents  for Cell Culture.  Culture medium was IKPMI- 
1640 supplemented  with  10% fetal calf serum,  gentamycin,  and 
2-mercaptoethanol (Biological Industries, Kibbutz Beit Haemek, 
Israel). 
Dendritic Cells.  A previously described standard procedure in- 
volving overnight  culture  and final purification by rosetting with 
Is-coated ox erythrocytes  (EAIgG) was applied for the prepara- 
tion of DC from spleen (6). Populations  obtained in this manner 
contained consistently >90% DC. 
Reagents and Cells  for the Stimulation of Dendritic Cells.  For  stim- 
ulation oflL-12 production in routine DC we used the following 
ess ￿9 0022-1007/96/08/741/06  $2.00 mAbs: hamster anti-mouse CD40 ligand/gp39 (clone MR.1, IgG; 
PharMingen, San Diego, CA), rat anti-mouse CD40 (clone 3/23, 
IgG2a;  Serotec, Oxford,  UK),  rat anti-mouse MHC  class II/I- 
A b,d (clone B21-2, IgG2b; TIB229 from the American Type Cul- 
ture  Collection  [ATCC],  RockviUe,  MD),  mouse  anti-I-E  k,d 
(clone 14-4-4S, IgG2a, HB32 from ATCC), and mouse anti-I-A  k 
(clone 10-2.16,  mouse lgG2a, TIB93 from ATCC). Hybridoma 
supematants were used at a final dilution of 1:5, purified antibod- 
ies at final concentrations of 1-10 Izg/ml. For inhibition experi- 
ments,  mAb anti-CD40 ligand was  applied at 50  p,g/ml, mAb 
Y-Ae (7) and T  cell hybridoma 1H3.1  (8), both specific for the 
I-E~ peptide 52-68 bound to I-A  b were kindly provided by Drs. 
R.  Germain  (Bethesda,  MD)  and  A.  Rudensky  (Seattle, WA). 
Dr. R.udensky also supplied us with control peptides: pigeon cy- 
tochrome  c  (PCC  88-104,  binds to  I-Ek);  moth  cytochrome c 
(m-cyt-c  88-103,  I-Ek/b);  undefined  (I-Ab).  All peptides were 
used at 5-10 p~M final concentration. Myoglobin peptide-specific 
T  cell hybridomas  11.3.7  (A~aE~-restricted)  and  13.26.8  (I-E  d- 
restricted)  (9)  and  myoglobin peptide  132-147  (10  ~,g/rnl final 
concentration) were  gifts  of Dr.  A. Livingstone (London, UK). 
Finally, sodium periodate-modified  primary naive murine CD4+ 
T cells were used as a stimulus for DC in the oxidative mitogene- 
sis  assay.  They  were  prepared from  nylon wool  non-adherent 
spleen  and  mesenteric  lymph  node  cells  by  treatment  with  a 
cocktail of mAbs  against MHC  class  II,  B220,  and  CD8  plus 
complement. Periodation was performed as described (10). Reg- 
ulation of IL-12 production by DC  was studied using recombi- 
nant  murine  IL-4  (specific  activity 1  ￿  107  U/mg)  and  IL-10 
(specific activity 5  ￿  10  s  U/mg), both purchased from Genzyme 
Corporation (Cambridge, MA). 
Measurement ofIL-12.  IL-12 was measured in 0-36 and 0-72 h 
supernatants of DC cultures (1  ￿  106 DC/1 ml/24 well) +  stim- 
ulation with the mAbs or cytokines mentioned above. Likewise, 
supernatants were analyzed after 36  and 72  h  of coculture with 
periodate-modified T  cells  or  T-T  hybridomas. Murine  IL-12 
p70 heterodimer was  detected by a two-site enzyme-linked im- 
munosorbent assay (ELISA) (11) using rat anti-mouse IL-  12 mAbs 
that  were  generously provided by Drs.  M.K.  Gately and  D.H. 
Presky (Hoffmann-La Roche, Nutley, NJ). 9A5 (anti-IL-12 p75) 
was used as capture antibody, 5C3  (anti-IL-12 p40) as detection 
antibody (11). Detection limit was about 20 pg/ml of IL-12. IL-12 
was also measured indirectly via determination oflNFy produced 
by Thl type T  cell blasts as described (5). 
Detection of  lL-12 mRNA by In Situ Hybridization.  This was done 
essentially as described (5) using a non-radioactive labeling system 
(Boehringer Mannheim, Mannheim, Germany). For detection of 
bound  digoxigenin-labeled probes  we  used  FITC-conjugated 
sheep anti-digoxigenin antibodies (Boehringer Mannheim). 
Detection of lL-12 mRNA by quantitative PCR and liquid hybrid- 
ization.  For the quantitative PCR.  the PCR  Mimic Construc- 
tion Kit  TM (No.  1700-1; Invitrogen, Leek, The Netherlands) was 
used  to  produce  a  neutral  DNA  fragment  spanning  548  bp, 
flanked by the IL-12 primers used for the PCR. For quantitation, 
IL-12 p40 PCR. was performed under standard conditions using 
the  same  amount  of template  cDNA  with  serial  dilutions  of 
mimic  DNA  (10-0,001  attomol/t*l  in  tenfold  dilutions  or  in 
some cases twofold dilutions spanning the concentration range of 
interest). The template DNA was quantitated by comparison of 
the  brightness of ethidium bromide stained bands  of amplified 
p40 versus minic DNA. Wincam  TM  software was employed for 
evaluation. The primers for murine IL-12 p40 were designed ac- 
cording to published sequences (12) and spanned one intron (bp 
Figure  1.  Non-radioactive in situ hybridization demonstrates that mu- 
rine spleen DC express IL-12 p40 mRNA upon contact with CD4+  T 
cells. A population of >95% DC was cocultured with allogeneic perio- 
dated CD4+  T cells at a ratio of 1:100 for 36 h. Clusters ofT cells and 
DC were analyzed. IL-12 p40 mP,  NA expression is evident in dendritic 
appearing cells (A) within the cluster. On parallel slides  from the same ex- 
periment DC within the aggregates  are identified by means ofanti-MHC 
class II staining (B). IL-12-negative and MHC  class II-negative  T  cells 
were made visible by counterstaining nuclei in red with propidium io- 
dide. DC by themselves express very little IL-12 mB.NA (see Fig. 3 B). 
150X. 
173-481):  3'  primer:  AACCTCACCTGTGACACGCC,  5' 
primer: CAAGTCCATGTTTCTTTGCACC. 
Results  and Discussion 
Dendritic  Cells  Produce IL-12  upon Interaction with  T  Cells. 
When purified murine spleen DC sensitized naive helper T 
cells in  an  oxidative mitogenesis assay we  found that sub- 
stantial amounts  (up  to  almost  5  ng/ml  from  106  DC)  of 
bioactive p70 heterodimer were released, yet only after 72 h. 
This was detected by a p70-specific ELISA (Table  I, rows 
A  vs.  B)  as well as by IFNy induction in  a  bioassay (data 
not shown). In addition, we observed a strong upregulation 
oflL-12 p40 mI<NA by in situ hybridization (Fig. 1).  Our 
earlier data strongly suggested (5) that in these experiments 
the source oflL-12 is the DC. 
The  delayed onset of IL-12 production suggested that a 
molecule that is upregulated by T  cells upon activation and 
could interact with a receptor on DC might be responsible 
for triggering IL-12 production in DC.  A  prime candidate 
was the CD40 ligand (CD40-L) as (a) CD40-L is expressed 
following T  cell activation (13)  and we  confirmed this by 
flow cytometry (Fig. 2, A  and B),  (b) CD40-L is known to 
interact with the CD40 molecule on mature, immunostim- 
ulatory DC,  and  to  induce  several biological effects  (e.g., 
upregulation of MHC  class I and II, adhesion and costimu- 
latory molecules) (14),  and (c)  CD40-L has been shown  to 
induce release oflL-12, albeit at lower levels (~< 100 pg/ml) 
from human (15) and murine (15a) monocytes. Addition of 
blocking anti-CD40-L mAb greatly reduced  IL-12 produc- 
tion (Table  1,  rows  B  vs.  C)  as well as p40  IL-12 mR.NA 
expression (not shown)  by DC  upon antigen-specific acti- 
vation of resting T  cells, indicating that the  CD40-L/CD40 
interaction is indeed a major trigger for production oflL-12. 
We  next  studied IL-12 production  upon  interaction  of 
DC  with  peptide-specific, MHC  class  II-restricted T  cell 
742  Regulation of Dendritic Cell-derived IL-12 Table  1.  Murine Spleen Dendritic Cells Produce  p70 IL-12 Protein and p40 IL-12 mRNA upon Interaction with Primary CD4 + 
T Cells and T Cell Hybridomas 
Inhibitory 
Row  DC  Stimulus 1  Stimulus 2  treatment  p70 IL-12  p40 ml~NA 
Expt.  No.  1  Expt.  No. 2 
A  DC  -  -  -  0  0 
B  DC  CD4+  T  cells  -  -  398  597 
C  DC  CD4+  T  cells  -  anti-CD40-L  124  - 
D  -  CD4+  T  cells  -  anti-CD40-L  0  - 
E  -  CD4+  T  cells  -  -  0  0 
Expt.  No. 3  Expt.  No. 4  Expt.  No. 4 
F  DC  -  -  -  0  0  - 
G  DC  hybrid 1H3.1  -  -  2890  1800  22 
H  DC  hybrid 1H3.1  -  anti-CD40-L  280  239  19 
I  DC  hybrid 1H3.1  Eet 52-68  -  4601  4342  97 
J  DC  hybrid 1H3.1  Eot 52-68  anti-CD40-L  1077  789  29 
K  DC  hybrid 1H3.1  PCC 88-104  -  2840  1224  - 
L  DC  -  E~x 52-68  -  -  0  - 
M  -  hybrid 1H3.1  -  -  0  0  0 
N  -  hybrid 1H3.1  Eo~ 52-68  -  0  0  0 
Dendritic cells (DC) were stimulated with primary CD4+  T cells (top, R.ows A-E) or with T hybridoma cells (bottom, F-N). Representative exper- 
iments are shown. Concentrations of IL-12 p70 heterodimer were determined by ELISA in 72 h supematants. Measurements after 36 h of stimula- 
tion were consistently negative. For PCP,, DC were stimulated for 36 h. Values are expressed as attomol p40 RNA/mg total KNA. Due to the 
strong proliferation ofhybridoma cells during the stimulation period the exact amount ofDC la.NA that was subjected to the quantitative PCK pro- 
cedure was unknown. For this reason a meaningful control with DC alone could not be done. DC and periodated CD4+  cells were from C57BL/6 
mice. Eo~ 52-68 and PCC 88-104 are I-Ec~ and pigeon cytochrome c peptides, respectively. 
I1 
,......,.,.  ....  .....  ,,..  ....  ,.,  ....  ,...  .....  :...  .....  ,, 
t 
Figure 2.  Expression ofCD40 hgand on T  cells. Periodated CD4+  T 
cells freshly isolated (A) or after 48 h of coculture with dendritic cells (B) 
and T  cell hybridoma 1H3.1  (C and D) were analyzed  by fluorescence 
flow cytometry using mAb anti-gp39. Large  cells (i.e.,  activated T  cell 
blasts) were  selected  by forward scatter/side scatter  gating in B.  CD40 
ligand (arrowed curve in each panel)  appears  on primary T  cells in re- 
hybridomas as a  model for activated T  cells. We  noted that 
even an antigen-nonspecific interaction (i.e., no peptide or 
control  peptide  added)  with  T  cell  hybridomas  induced 
high levels of IL-12  (Table  1,  rows  F  vs.  G  and K).  Pro- 
duction of IL-12 was,  however, still higher in the presence 
of the appropriate peptide  enabhng antigen-specific activa- 
tion of the T  cell hybridomas (Table 1, rows  G  vs./). Using 
anti-CD40-L  mAb,  we  found  that the T  cell hybridomas 
increased  their constitutive  CD40-L  expression further,  as 
expected, upon activation (Fig. 2,  C  and D). Anti-CD40-L 
prevented  most  of  the  IL-12  production,  that  occurred 
upon  mixing DC  with T-T  hybrid cells.  However,  block- 
ing was incomplete notably in the case of the antigen-spe- 
cific  interaction  (Table  1,  rows  B  vs.  C  and  I  vs. J).  The 
same observations were made with two myoglobin-specific 
T  cell hybridomas (not shown). 
sponse to activation by dendritic cells (A vs. B). The T-T hybrid shows 
low constitutive expression  (C) and a marked upregulation following acti- 
vation with 2  p.M ionomycin for 12 h  (D). Unlabeled curves represent 
controls with irrelevant hamster Ig. 
743  Koch et al.  Brief Definitive Report Table  2.  Murine  Spleen Dendritic Cells Produce  p 70 IL-12 upon Ligation of MHC Class H and CD40 Molecules 
p70 IL-12 




-  -  0  0  0  0  0  0 
anti-CD40  -  3935  625  670  750  817  674 
-  anti-I-A  1695  -  463*  472  4319  - 
anti-CD40  anti-I-A  5153  ..... 
-  anti-I-E  -  184  431  417  -  - 
-  anti-I-A +  I-E  -  200  .... 
anti-CD40  anti-I-E  -  700  .... 
0  26 
1188  94 
-  40 
-  80 
-  51 
Eo~ 52-68  -  0  0  0  0  0 
Ec~ 52-68  mAb Y-Ae  0  0  637  626  628 
-  mAb Y-Ae  0  0  0  0  0 
Dendritic cells of different mouse strains were treated with the listed stimuli and p70 IL-12 was determined by ELISA in 72 h supematants. Measure- 
ments after 36 h of stimulation were consistently negative. For quantitative PCP, for IL-12 p40 ~far  right column), DC were stimulated for 36 h. Values 
are  expressed  as attomol p40 RNA/mg total RNA.  (Upper  part) Stimulation with anti-CD40 and anti-MHC class II mAbs; (lower  part) stimulation 
with mAb Y-Ae, specific for the Ea 52-68/I-A  b complex. 
*In these experiments control peptides (moth and pigeon cytochrome-c, myoglobin, and an undefined peptide; see Materials and Methods), all at 5-1{) 
~M, were negative. Solvent control (DMSO) was also negative. 
*A different anti-I-A  a mAb (MKD6) gave 535 pg/ml and ~ a different anti-l-A  h (M5-114) mAb yielded 483 pg/ml. 
Figure  3.  Non-radioactive in situ hybridization demonstrates that mu- 
rine spleen  DC  express  IL-12 p40 mRNA upon ligation of CD40 and 
MHC class II molecules.  A population of >95% DC was incubated for 36 
h in the absence of stimuli (B) or in the presence of anti-CD40 mAbs (C) 
or anti-MHC class II mAbs (D).  Compare the very weak signal in un- 
'"  related  DC  (A) with the strongly  upregulated IL-12 p40 mlKNA ex- 
Dendritic  Cells  Produce  IL-12  upon  Ligation  of CD40  and 
MHC  Class IIMolecules.  We  next  used  purified  murine 
spleen  DC  and  several  mAbs  to  search  for  the  molecular 
signals  that trigger  IL-12  production  in  DC.  Binding  of a 
stimulatory  mAb  to  CD40  induced  the  release  of  large 
amounts of p70  IL-12  (Table 2,  top two rows) substantiating 
the  conclusion  drawn  from  the  anti-CD40-L  blocking 
studies  (see  above)  that  ligation  of  CD40  triggers  IL-12 
production  in DC.  In  17  experiments  the  range  for  IL-12 
production in this system was 263-4726  pg/ml  of p70 het- 
erodimer.  Strain differences were  not observed. Binding of 
anti-MHC  class  II  mAbs  also  reproducibly  induced  IL-12 
release although at ,'~  lower levels as compared to trig- 
gering IL-12 production via the CD40  molecule  (Table 2). 
Interestingly,  simultaneous  triggering  of MHC  class  II  as 
well as CD40  molecules had an additive effect. 
In  addition  to  the  anti-MHC  class  II  mAbs  we  also 
tested  the  peptide  Ea  52-68  as  a  physiological  ligand  for 
MHC.  This peptide binds to I-A  b and d MHC  class II mole- 
cules  and can be detected by the Y-Ae  mAb.  This unique 
antibody binds to the complex of an I-Ee~ peptide and I-A  b 
(but  not  I-Aa),  and,  like  a  TCP,  recognizes  both  the  Eo~ 
52-68 peptide and polymorphic  MHC  class II  residues  (7). 
Upon  binding of the mAb  Y-Ae  to  the Eot  52-68  +  I-A  b 
pression  in response  to either stimulus  (C and D).  Control hybridization 
of anti-class II-treated DC with sense RNA probe is shown in A.  150￿ 
(A and B); 250￿  (C and D). 
744  Regulation of Dendritic Cell-derived IL-12 Table 3.  lnterleukin-4 and Interleukin-10 Downregulate IL-12 
p 70 Production in Murine Spleen Dendritic Cells 
Stimulus/Cytokines  p70 IL-12 
pg/ml 
No stimulus  -  0  0 
CD4+ T cells  398  -  - 
CD4+ T cells 
IL-4 (200 U/ml)  48  -  - 
CD4+ T cells 
IL-10 (2.5 U/ml)  0  -  - 
Anti-CD40  -  727  321 
Anti-CD40 
IL-4 (50, 200 U/ml)  -  43, 0  0, 0 
Anti-CD40 
IL-10 (0.1, 1 U/ml)  -  0, 0  0, 0 
Dendritic  cells from  C57BL/6  mice  were  stimulated with  primary 
CD4+ T cells or with mAb against CD40. IL-12 p70 heterodimer was 
determined  by ELISA after 72  h  of stimulation. IL-10  completely 
blocks IL-12 production.  IL-4 leads to substantial inhibition and also 
blocks at higher concentrations. 
complex, DC released substantial amounts of IL-12 (Table 
2).  I-Ab-binding (an  undefined  peptide)  and  non-binding 
(PCC 88-104, m-cyt-c 88-103, myoglobin 132-147)  con- 
trol peptides  did not induce IL-12 production irrespective 
of the presence ofmAb Y-Ae. Conversely, peptide Eoe 52- 
68,  with  or without  mAb Y-Ae,  was  inactive  on DC  of 
binding (BALB/c -  H-2  a) and non-binding (C3H -  H-2  k) 
MHC  class  II  haplotypes  (Table  2).  These  findings  sup- 
ported  the  conclusion  drawn  from the  experiments  using 
DC and T  cell hybridomas (including the T  cell hybridoma 
1H3.1  that  recognizes  the  very  same  Eci  52-68  +  I-A  6 
complex [8], see above and Table  1) that ligation of MHC 
class II molecules directly signals IL-12 production in DC, 
independent of the indirect effect of CD40-L upregulation 
on T  cells via TCP,-mediated activation (13). 
Quantitative  P,T-PCP,  and  non-radioactive  in situ  hy- 
bridization  demonstrated  that the induction  of IL-12 pro- 
duction via CD40 and MHC  class II molecules is transcrip- 
tionally regulated  (Tables  1 and 2,  Fig.  3).  In situ analyses 
showed furthermore that IL-12 mRNA is induced in virtu- 
ally all DC and is not restricted to subsets. 
IL-4 and IL-10 Downregulate IL-12 Production by Dendritic 
Cells.  Downregulation oflL-12 production by DC might 
be biologically relevant with regard to Thl  skewing of the 
immune  response  (1)  and  tolerance  (16).  We  therefore 
tested the effect oflL-4 and IL-10 which both can suppress 
IL-12 production by mononuclear phagocytes (17,  18). IL-10 
as well as IL-4 were also able to suppress T  cell-induced as 
well as anti-CD40 mAb-triggered IL-12 production in DC 
(Table 3).  In a pilot experiment DC were stimulated for 24 h 
with anti-CD40 mAb in the presence of IL-4 or IL-10 fol- 
lowed by thorough washing and continued culture for an- 
other  56  h  in the  absence  of IL-4 or IL-10.  Induction of 
IL-12 was much lower (272 and 90 pg/ml, respectively) as 
compared with control cultures that had been without cy- 
tokines  and/or  without  anti-CD40  during  the  first  24  h 
(885  and  >1000  pg/ml,  respectively).  This  suggests  that 
the inhibitory effects of IL-4 and IL-10 are not fully irre- 
versible.  Downregulation  of IL-12  production  in  DC  as 
well as other antigen presenting cells (17,  18)  explains why 
both  IL-10  and  IL-4  suppress  Thl  development  (19). 
Downregulation  of IL-12 production  by  IL-10  may  also 
contribute to development of hapten-specific tolerance  (20) 
as  the  induction  of contact  hypersensitivity  critically  de- 
pends  on DC-derived  IL-12  (16).  It appears also that  IL-4 
drives Th2 development so potently as it does not only di- 
rectly  act  on  precursor  T  cells  (19)  but  in  addition  also 
downregulates IL-12 production in antigen-presenting cells 
including DC. 
Possible Biological Relevance of T Cell-induced IL-12 Produc- 
tion by Dendritic Cells.  It is evident that antigen-presenting 
cells including DC release  IL-12 upon antigen-specific in- 
teraction with  T  cells,  and can thus skew the immune re- 
sponse  to  Thl  including  IFN~ production  from resulting 
Thl  cells  (2,  5).  We  have  shown  here  that ligation  by T 
cells  of MHC  class II as well as CD40 molecules indepen- 
dently triggers high levels oflL-12 production in DC. Rel- 
ative  to  macrophages  and  B  cells,  DC  can  make  larger 
amounts of IL-12. The induction of IL-12 production via 
the CD40 molecule readily explains our finding that helper 
T  cells,  upon activation and expression of CD40-L, can in- 
duce IL-12 production even in the absence of cognate anti- 
gen  recognition  by  T  cells.  By  making  so  much  IL-12 
upon  contact  with  T  cells,  either  via  MHC  class  II  or 
CD40,  the  DC  would  skew  these  T  cells  towards  a  Thl 
phenotype  (5)  and thus  promote strong cell mediated im- 
munity. 
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